Insider Transactions in Q2 2024 at Owens & Minor Inc (OMI)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 06
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Open market or private sale
|
Direct |
20,015
-3.5%
|
$340,255
$17.48 P/Share
|
Jun 05
2024
|
Mark A Beck Director |
SELL
Open market or private sale
|
Direct |
9,344
-45.58%
|
$158,848
$17.25 P/Share
|
Jun 04
2024
|
Snehashish Sarkar |
SELL
Open market or private sale
|
Direct |
9,980
-14.44%
|
$169,660
$17.32 P/Share
|
Jun 03
2024
|
Alexander J Bruni EVP, CFO |
SELL
Open market or private sale
|
Direct |
10,568
-17.46%
|
$179,656
$17.76 P/Share
|
Jun 03
2024
|
Jennifer A Stone EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
57,078
+50.0%
|
-
|
May 17
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-3.22%
|
$33,592
$19.11 P/Share
|
May 17
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Open market or private sale
|
Direct |
2,052
-3.61%
|
$38,988
$19.06 P/Share
|
May 16
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Open market or private sale
|
Direct |
2,031
-3.45%
|
$40,620
$20.18 P/Share
|
May 15
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,204
-3.78%
|
$60,876
$19.78 P/Share
|
May 15
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
27,372
-10.96%
|
$520,068
$19.78 P/Share
|
May 15
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,077
-2.62%
|
$39,463
$19.78 P/Share
|
May 15
2024
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
4,322
-5.89%
|
$82,118
$19.78 P/Share
|
May 15
2024
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,604
-5.7%
|
$866,476
$19.78 P/Share
|
May 15
2024
|
Daniel J Starck EVP, Business Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
9,446
-8.99%
|
$179,474
$19.78 P/Share
|
May 15
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,752
-2.89%
|
$33,288
$19.78 P/Share
|
May 15
2024
|
Alexander J Bruni EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,290
-8.04%
|
$100,510
$19.78 P/Share
|
May 15
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
20,962
-12.29%
|
$398,278
$19.78 P/Share
|
May 09
2024
|
Mark A Beck Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+35.24%
|
-
|
May 09
2024
|
Stephen W Klemash Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+27.01%
|
-
|
May 09
2024
|
Teresa L. Kline Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.67%
|
-
|
May 09
2024
|
Rita Johnson Mills Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.67%
|
-
|
May 09
2024
|
Carissa Rollins Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.86%
|
-
|
May 09
2024
|
Kenneth Gardner Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.01%
|
-
|
May 09
2024
|
Robert J Henkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+18.7%
|
-
|
May 01
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Open market or private sale
|
Direct |
24,094
-6.3%
|
$578,256
$24.4 P/Share
|
Apr 22
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.58%
|
$120,000
$24.84 P/Share
|